Safety Results of Two Phase III Trials of an Intravitreous Injection of Highly Purified Ovine Hyaluronidase (Vitrase®) for the Management of Vitreous Hemorrhage
- 22 August 2005
- journal article
- clinical trial
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 140 (4) , 585.e1-585.e15
- https://doi.org/10.1016/j.ajo.2005.06.022
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Vitreoretinal surgery for complications of branch retinal vein occlusionCurrent Opinion in Opthalmology, 2002
- Eales Disease—An UpdateSurvey of Ophthalmology, 2002
- Outcomes of vitreoretinal surgery for complications of branch retinal vein occlusionOphthalmology, 2001
- Vitreous hemorrhageSurvey of Ophthalmology, 1997
- Age-Related Macular Degeneration and Vitreous HemorrhageEuropean Journal of Ophthalmology, 1991
- VITRECTOMY FOR NONDIABETIC VITREOUS HEMORRHAGERetina, 1988
- Hyaluronic acid enhances phagocytosis of human monocytesin vitroJournal of Clinical Immunology, 1984
- The Mechanism of Action of HyaluronidasesJournal of Biological Chemistry, 1961
- EXPERIMENTAL STUDY ON THE VITREOUSArchives of Ophthalmology (1950), 1950